Low complement levels are related to poor obstetric outcomes in women with obstetric antiphospholipid syndrome. The EUROAPS Registry Study Group.

[1]  J. Wetterö,et al.  Variation of Complement Protein Levels in Maternal Plasma and Umbilical Cord Blood during Normal Pregnancy: An Observational Study , 2022, Journal of clinical medicine.

[2]  G. Espinosa,et al.  The antiphospholipid syndrome , 2021, Revista Colombiana de Reumatología.

[3]  P. Conigliaro,et al.  Low Preconception Complement Levels Are Associated with Adverse Pregnancy Outcomes in a Multicenter Study of 260 Pregnancies in 197 Women with Antiphospholipid Syndrome or Carriers of Antiphospholipid Antibodies , 2021, Biomedicines.

[4]  S. Fleming,et al.  Essential Role of Complement in Pregnancy: From Implantation to Parturition and Beyond , 2020, Frontiers in Immunology.

[5]  Xiangyuan Liu,et al.  Clinical features associated with pregnancy outcomes in women with positive antiphospholipid antibodies and previous adverse pregnancy outcomes: a real-world prospective study , 2020, Clinical Rheumatology.

[6]  J. Cesbron,et al.  The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease , 2019, Clinical Reviews in Allergy & Immunology.

[7]  M. Ling,et al.  Analysis of the Complement System in the Clinical Immunology Laboratory. , 2019, Clinics in laboratory medicine.

[8]  P. Benedetti Panici,et al.  Complementemia in pregnancies with antiphospholipid syndrome , 2019, Lupus.

[9]  S. Meri,et al.  Regulation of the complement system and immunological tolerance in pregnancy. , 2019, Seminars in immunology.

[10]  K. McCrae,et al.  Complement in the Pathophysiology of the Antiphospholipid Syndrome , 2019, Front. Immunol..

[11]  K. Lackner,et al.  Pathogenesis of antiphospholipid syndrome: recent insights and emerging concepts , 2018, Expert review of clinical immunology.

[12]  Mimi Y. Kim,et al.  Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies , 2018, Annals of the rheumatic diseases.

[13]  A. Graham,et al.  Thrombotic Microangiopathies (TTP, HUS, HELLP). , 2017, Hematology/oncology clinics of North America.

[14]  C. Kemper,et al.  The “ins and outs” of complement‐driven immune responses , 2016, Immunological reviews.

[15]  R. Burwick,et al.  The complement system and adverse pregnancy outcomes. , 2015, Molecular immunology.

[16]  G. Espinosa,et al.  The European Registry on Obstetric Antiphospholipid Syndrome (EUROAPS): A survey of 247 consecutive cases. , 2015, Autoimmunity reviews.

[17]  R. Burwick,et al.  Eculizumab for the treatment of preeclampsia/HELLP syndrome. , 2013, Placenta.

[18]  A. Tincani,et al.  Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications? , 2012, Rheumatology.

[19]  G. Sordo,et al.  Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome , 2012, Lupus.

[20]  A. Tincani,et al.  Risk factors for pregnancy failure in patients with anti-phospholipid syndrome treated with conventional therapies: a multicentre, case-control study. , 2011, Rheumatology.

[21]  M. Khamashta,et al.  Antiphospholipid syndrome , 2010, The Lancet.

[22]  F. Colombo,et al.  Complement production by trophoblast cells at the feto-maternal interface. , 2009, Journal of reproductive immunology.

[23]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[24]  J. Salmon,et al.  Heparin prevents antiphospholipid antibody–induced fetal loss by inhibiting complement activation , 2004, Nature Medicine.

[25]  Qing‐Yu He,et al.  The Embryotrophic Activity of Oviductal Cell-derived Complement C3b and iC3b, a Novel Function of Complement Protein in Reproduction* , 2004, Journal of Biological Chemistry.

[26]  J. Lambris,et al.  Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. , 2003, The Journal of clinical investigation.

[27]  D. Anderson,et al.  The role of complement component C3b and its receptors in sperm-oocyte interaction. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Alijotas-Reig,et al.  [Treatment with immunosuppressive and biologic drugs of pregnant women with systemic rheumatic or autoimmune disease]. , 2016, Medicina clínica (Ed. impresa).